Moderna, Inc.
MRNA
$49.04
-$0.99-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.09B | 1.82B | 2.11B | 2.96B | 3.03B |
| Total Other Revenue | 140.00M | 125.00M | 121.00M | 120.00M | 149.00M |
| Total Revenue | 2.23B | 1.94B | 2.23B | 3.08B | 3.18B |
| Cost of Revenue | 3.78B | 4.00B | 4.63B | 5.28B | 5.79B |
| Gross Profit | -1.56B | -2.06B | -2.40B | -2.20B | -2.62B |
| SG&A Expenses | 979.00M | 1.02B | 1.06B | 1.07B | 1.11B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.76B | 5.02B | 5.70B | 6.35B | 6.91B |
| Operating Income | -2.53B | -3.07B | -3.46B | -3.27B | -3.73B |
| Income Before Tax | -3.14B | -2.77B | -3.15B | -2.95B | -3.41B |
| Income Tax Expenses | 56.00M | 54.00M | -37.00M | -42.00M | -49.00M |
| Earnings from Continuing Operations | -3.19K | -2.82K | -3.12K | -2.90K | -3.36K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.19B | -2.82B | -3.12B | -2.90B | -3.36B |
| EBIT | -2.53B | -3.07B | -3.46B | -3.27B | -3.73B |
| EBITDA | -2.30B | -2.86B | -3.26B | -3.07B | -3.54B |
| EPS Basic | -8.15 | -7.26 | -8.06 | -7.52 | -8.72 |
| Normalized Basic EPS | -3.61 | -4.44 | -5.08 | -4.73 | -5.45 |
| EPS Diluted | -8.15 | -7.26 | -8.07 | -7.52 | -8.73 |
| Normalized Diluted EPS | -3.61 | -4.44 | -5.08 | -4.73 | -5.45 |
| Average Basic Shares Outstanding | 1.57B | 1.56B | 1.55B | 1.54B | 1.54B |
| Average Diluted Shares Outstanding | 1.57B | 1.56B | 1.55B | 1.56B | 1.55B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |